Collaboration underscores both companies’ commitment to advancing patient-centric solutions and expanding access to therapies through novel drug delivery technologies Under the terms of the agreement, ...
Incyte (INCY) and Enable announced a new partnership to develop and commercialize specific assets in Incyte’s portfolio, including its investigational mutant calreticulin selective monoclonal antibody ...
CINCINNATI (WKRC) - A company in Evendale is changing medicine through a breakthrough device that gives patients a way to take certain medications at home. Its purpose is to redefine drug delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results